Market Overview

Benzinga's Top #PreMarket Gainers


Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares rose 21.21 percent to $1.200 after the company reported that the U.S. FDA has granted Orphan Drug Designation to Pluristem's PLX-PAD cells.

Prima BioMed Ltd (ADR) (NASDAQ: PBMD) shares rose 12.61 percent to $1.25. Roth initiated coverage on PBMD with a Buy rating and a $6 price target.

Chimerix Inc (NASDAQ: CMRX) shares rose 7.90 percent to $9.01. Steven Cohen reported a 5.3 percent stake in Chimerix.

Perion Network Ltd (NASDAQ: PERI) shares rose 4.07 percent to $3.84 in pre-market trading after the company raised its Q4 forecast.

Vodafone Group Plc (ADR) (NASDAQ: VOD) shares rose 1.77 percent to $32.69 in pre-market trading after falling 0.86 percent on Wednesday.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (PBMD + CMRX)

View Comments and Join the Discussion!

Fast Money Traders Give Their Crude Oil Trades

US Stock Futures Edge Lower Ahead Of Jobless Claims Data